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Abstract  Postoperative  sore  throat  is  a  common  complication  after  endotracheal  intubation.
After tracheal  intubation,  the  incidence  of  sore  throat  varies  from  14.4%  to  50%.  The  aim  of  the
study was  to  compare  between  benzydamine  hydrochloride  gel,  lidocaine  5%  gel  and  lidocaine
10% spray  on  the  endotracheal  tube  cuff  as  regards  postoperative  sore  throat.  The  present
study was  carried  out  on  124  patients  admitted  to  Alexandria  university  hospitals  for  lumbar
ﬁxation surgery  requiring  general  anesthesia.  Patients  were  randomly  allocated  into  4  groups.
Benzydamine  hydrochloride  gel,  5%  lidocaine  hydrochloride  gel,  10%  lidocaine  hydrochloride
spray, or  normal  saline  were  applied  on  endotracheal  tube  cuffs  before  endotracheal  intuba-
tion. The  patients  were  examined  for  sore  throat  (none,  mild,  moderate,  or  severe)  at  0,  1,
6, 12,  and  24  h  after  extubation.  The  results  were  collected,  analyzed  and  presented  in  table
and ﬁgure.  The  highest  incidence  of  postoperative  sore  throat  occurred  at  6  h  after  extuba-
tion in  all  groups.  There  was  a  signiﬁcantly  lower  incidence  of  postoperative  sore  throat  in  the
benzydamine  group  than  5%  lidocaine  gel,  10%  lidocaine  spray,  and  normal  saline  groups.  The
benzydamine  group  had  signiﬁcantly  decreased  severity  of  postoperative  sore  throat  compared
with the  10%  lidocaine,  5%  lidocaine,  and  normal  saline  groups  at  observation  time  point.  Com-
pared with  the  5%  lidocaine  the  10%  lidocaine  group  had  signiﬁcantly  increased  incidence  and
severity  of  postoperative  sore  throat  after  extubation.  Compared  with  normal  saline  the  10%
lidocaine  group  had  increased  incidence  of  postoperative  sore  throat.  There  were  no  signiﬁ-ups  in  local  or  systemic  side  effects.  So  in  conclusion,  benzydamine
dotracheal  tube  cuff  is  a  simple  and  effective  method  to  reduce  the
ostoperative  sore  throat.  Application  of  10%  lidocaine  spray  should
sening  of  postoperative  sore  throat  where  incidence  increased  butcant differences  among  gro
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not  the  severity  in  relation  to  5%  lidocaine  gel.  Applying  5%  lidocaine  on  the  endotracheal  tube
cuff does  not  prevent  postoperative  sore  throat  but  its  application  is  better  than  lidocaine  10%
spray or  saline.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.
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Estudo  comparativo  entre  cloridrato  de  benzidamina  em  gel,  lidocaína  a  5%  em  gel  e
lidocaína  a  10%  em  spray  no  balonete  do  tubo  endotraqueal  em  relac¸ão à  dor  de
garganta  pós-operatória
Resumo  A  dor  de  garganta  pós-operatória  (DGPO)  é  uma  complicac¸ão  comum  após  a  intubac¸ão
traqueal.  Em  seguida  a  esse  procedimento,  a  incidência  de  dor  de  garganta  varia  de  14,4  a  50%.
O objetivo  do  estudo  foi  comparar  os  efeitos  da  aplicac¸ão  de  cloridrato  de  benzidamina  em
gel, lidocaína  a  5%  em  gel,  e  lidocaína  a  10%  em  spray  no  balonete  do  tubo  endotraqueal,  no
que diz  respeito  à  dor  de  garganta  pós-operatória.  O  presente  estudo  foi  realizado  em  124
pacientes  internados  em  hospitais  universitários  de  Alexandria  para  cirurgia  de  ﬁxac¸ão  lombar
necessitando  de  anestesia  geral.  Os  pacientes  foram  aleatoriamente  alocados  em  quatro  grupos.
Procedeu-se  à  aplicac¸ão  de  cloridrato  de  benzidamina  em  gel,  cloridrato  de  lidocaína  a  5%  em
gel, cloridrato  de  lidocaína  a  10%  em  spray,  ou  salina  normal  nos  balonetes  do  TET  antes  da
intubac¸ão endotraqueal.  Os  pacientes  foram  examinados  para  dor  de  garganta  (nenhuma,  leve,
moderada  ou  intensa)  a  0,  1,  6,  12  e  24  horas  após  a  extubac¸ão.  Os  resultados  foram  coletados,
analisados  e  apresentados  em  tabelas  e  ﬁguras.  A  maior  incidência  de  DGPO  ocorreu  6  horas
após a  extubac¸ão  em  todos  os  grupos.  Houve  incidência  signiﬁcativamente  menor  de  DGPO  no
grupo de  benzidamina  versus  grupos  de  lidocaína  a  5%  em  gel,  lidocaína  a  10%  em  spray,  e
salina normal.  O  grupo  tratado  com  benzidamina  exibiu  reduc¸ão  signiﬁcativa  na  intensidade
da DGPO,  em  comparac¸ão  com  os  grupos  de  lidocaína  a  10%,  lidocaína  a  5%  e  salina  normal
no ponto  no  tempo  de  observac¸ão.  Em  comparac¸ão  com  lidocaína  a  5%,  o  grupo  tratado  com
lidocaína  a  10%  exibiu  incidência  e  intensidade  signiﬁcativamente  aumentadas  na  DGPO  após
a extubac¸ão.  Em  comparac¸ão  com  salina  normal,  o  grupo  tratado  com  lidocaína  a  10%  exibiu
maior incidência  de  DGPO.  Não  foram  observadas  diferenc¸as  signiﬁcativas  entre  grupos  quanto  a
efeitos colaterais  locais  ou  sistêmicos.  Assim,  em  conclusão,  o  uso  de  cloridrato  de  benzidamina
em gel  no  balonete  do  TET  é  um  método  simples  e  eﬁcaz  para  reduzir  a  incidência  e  gravidade
da DGPO.  Deve-se  evitar  a  aplicac¸ão  de  lidocaína  a  10%  em  spray,  devido  ao  agravamento  da
DGPO, visto  ter  ocorrido  aumento  na  incidência,  mas  não  na  severidade,  em  relac¸ão  à  lidocaína
a 5%  em  gel.  A  aplicac¸ão  de  lidocaína  a  5%  no  balonete  do  TET  não  impede  a  ocorrência  da
DGPO, mas  a  sua  aplicac¸ão  oferece  melhores  resultados  do  que  lidocaína  a  10%  em  spray,  ou
soluc¸ão salina.
©  2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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Sore  throat  is  a  common  postoperative  complaint.  After  tra-
cheal  intubation,  the  incidence  of  sore  throat  varies  from
14.4%  to  50%  and  after  laryngeal  mask  insertion  from  5.8%
to  34%.  The  highest  incidence  of  sore  throat  and  other  air-
way  related  symptoms  tends  to  occur  in  patients  who  have
undergone  tracheal  intubation.1
Complications  of  tracheal  intubation  can  be  classiﬁed  as
immediate,  early  and  late.  It  is  well  recognized  that  pro-
longed  intubation  can  have  serious  consequences,  but  it  is
less  well  recognized  that  uneventful  intubation  for  routine
surgical  procedures  can  also  cause  pathological  changes  that
may  provide  an  organic  basis  for  patients’  postoperative
throat  symptoms.2
s
sSeveral  pharmacological  methods  have  been  suggested
o  reduce  postoperative  sore  throat  (POST)  including  inhal-
ng  beclomethasone;  applying  lidocaine  spray  or  lidocaine
el  to  the  endotracheal  tube  (ETT);  administering  aspirin,
etamine,  or  benzydamine  hydrochloride.3
Local  anesthetic  drugs  act  by  producing  a  reversible
lock  to  the  transmission  of  peripheral  nerve  impulses.  Lido-
aine  is  used  commonly  for  inﬁltration  in  concentrations  of
.5--1.0%  and  for  peripheral  nerve  blocks  if  an  intermedi-
te  duration  is  required.  Lidocaine  2--4%  is  used  by  many
nesthetists  as  a  topical  solution  for  anesthesia  of  the  upper
irway  before  awake  intubation.3In  most  cases,  postoperative  throat  complaints  resolve
pontaneously  without  speciﬁc  treatment.  In  moderate  to
evere  cases  it  may  be  beneﬁcial  to  treat  pain  and  dysphagia
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ith  a  gargle  containing  a  drug  such  as  benzydamine
ydrochloride,  which  is  approved  for  the  symptomatic  treat-
ent  of  acute  sore  throat  pain.4
Benzydamine  hydrochloride  is  a  topical  non-steroidal
nti-inﬂammatory  agent  that  also  has  local  anesthetic
ctivity.5 It  has  an  alkaline  pH,  which  means  that  it  becomes
oncentrated  in  inﬂamed  tissue  and  has  minimal  systemic
bsorption.5
It  has  been  reported  that  moderate  to  severe  sore  throat
ay  be  resolved  with  gargling  benzamine  hydrochloride.6
reventive  topical  benzamine  hydrochloride  applied  to  the
ropharyngeal  cavity  before  endotracheal  intubation  or
efore  endotracheal  intubation  and  continuously  for  48  h
ostoperatively  has  been  reported  to  decrease  the  incidence
nd  severity  of  POST  after  ETT  insertion  and  laryngeal  mask
irway  insertion.6
im of the work
he  aim  of  the  study  was  to  compare  between  benzydamine
ydrochloride  gel,  lidocaine  5%  gel  and  lidocaine  10%  spray
n  the  ETT  cuff  as  regards  POST.
ethods
he  present  study  was  carried  out  on  124  patients  admitted
o  Alexandria  university  hospitals  undergoing  lumbar  ﬁxation
urgery  requiring  general  anesthesia.
nclusion  criteria
atients  of  American  Society  of  Anesthesiologists  (ASA)  phys-
cal  status  I  or  II  2,  Lumbar  ﬁxation  surgery  requiring  general
nesthesia.
xclusion  criteria
istory  of  preoperative  sore  throat,  More  than  one  attempt
t  intubation,  Mallampati  grade  more  than  2,  Known
llergies  to  benzydamine  hydrochloride  or  lidocaine  and
moking.
After  approval  of  the  local  ethical  committee  and  having
n  informed  written  consent  from  every  patient,  they  were
andomly  categorized;  by  closed  envelope  method;  into  four
roups  (31  each):
Group  I:  where  the  ETT  cuffs  were  lubricated  with  benzy-
damine  hydrochloride  gel.
Group  II:  where  the  ETT  cuffs  were  lubricated  with  lido-
caine  hydrochloride  5%  gel.
Group  III:  where  the  ETT  cuffs  were  sprayed  with  lidocaine
hydrochloride  10%  spray.
Group  IV:  where  the  cuffs  were  sprayed  with  normal  saline
as  a  control  group.
Anesthesia  was  induced  with  fentanyl  2--3  microgram/kg
nd  propofol  2--2.5  mg/kg.  Tracheal  intubation  was  facil-
tated  by  rocuronium  0.6  mg/kg,  and  the  trachea  was
ntubated  with  a  low  pressure  cuffed  sterile  polyvinyl  chlo-
ide  ETT.  The  cuff  was  inﬂated  with  air  and  cuff  pressure
s
6
gN.A.  Mekhemar  et  al.
as  maintained  at  20  cmH2O  using  cuff  pressure  gauge.  We
ept  the  cuffs  pressure  uniform  for  the  4  groups  using  cuff
ressure  gauge.  Anesthesia  was  maintained  using  isoﬂurane
AC  1.2%  and  increments  of  fentanyl  and  rocuronium.
Monitoring  consisted  of  5-lead  electrocardiography,  non-
nvasive  arterial  blood  pressure,  pulse  oximetry,  nasopha-
yngeal  temperature,  and  end  tidal  carbon  dioxide,  which
as  kept  between  30  and  35  mm  Hg.  At  the  end  of  surgery,
he  muscle  relaxation  was  reversed  by  a  combination  of
eostigmine  0.05  mg/kg  and  atropine  0.02  mg/kg.  After  gen-
le  suctioning  of  oral  secretions  by  a  12  F  suction  catheter,
atients  were  extubated  and  transferred  to  the  post-
nesthesia  care  unit.
The  following  were  recorded:
-  Age,  sex,  weight  and  height  of  the  patients.
-  Duration  of  surgery.
-  Total  fentanyl  consumption.
-  Vital  signs.
- Postoperative  analgesia.
-  Potential  side  effects  associated  with  tracheal  intubation.
POST  was  graded  at  (0  h)  after  full  recovery  and  there-
fter  at  1,  6,  12  and  24  h  after  extubation,  on  a  4-point
cale  (0--3)  as  shown  below7:  0  --  No  sore  throat;  1  --  Mild
ore  throat  (complains  of  sore  throat  only  on  asking);  2  --
oderate  sore  throat  (complains  of  sore  throat  on  his/her
wn);  3  --  Severe  sore  throat  (change  of  voice  or  hoarseness,
ssociated  with  throat  pain).
esults
he  age  in  group  I ranged  from  35.0  to  60.0  years  with  a
ean  of  48.74  ±  6.21  years;  in  group  II;  it  ranged  from  39.0
o  61  years  with  a  mean  of  49.55  ±  6.81  years;  in  group  III  it
anged  from  35.0  to  60.0  years  with  a  mean  of  48.39  ±  6.49
ears  and  in  group  IV  it  ranged  from  40.0  to  61.0  years  with
 mean  of  49.84  ±  6.08  years.  There  was  no  signiﬁcant  dif-
erence  between  mean  ages  in  the  four  groups.
The  sex  of  patients  in  group  I  was  as  follows:  67.7%
ales  and  32.3%  females;  in  group  II:  58.1%  males  and  41.9%
emales;  in  group  III:  61.3%  males  and  38.7%  females  and
n  group  IV:  58.1%  males  and  41.9%  females.  There  was  no
igniﬁcant  difference  between  groups  as  regards  sex.
The  weight  of  patients  in  group  I  ranged  from  82.0  to
30.0  kg  with  a  mean  of  97.77  ±  10.57  kg;  in  group  II  ranged
rom  82.0  to  120.0  kg  with  a  mean  of  97.32  ±  9.36  kg;  in
roup  III  ranged  from  70.0  to  120.0  kg  with  a  mean  of
3.90  ±  11.30  kg;  while  in  group  IV  ranged  from  79.0  to
20.0  kg  with  a  mean  of  95.32  ±  8.87  kg.  There  was  no  sig-
iﬁcant  difference  between  groups  as  regards  weight.
The  height  of  patients  in  group  I ranged  from  160.0  to
89.0  cm  with  a  mean  of  173.13  ±  8.10  cm;  in  group  II ranged
rom  160.0  to  184.0  cm  with  a  mean  of  171.94  ±  7.51  cm;
n  group  III  ranged  from  160.0  to  183.0  cm  with  a  mean  of
72.19  ±  6.95  cm;  while  in  group  IV  ranged  from  163.0  to
85.0  cm  with  a  mean  of  173.26  ±  6.56  cm.  There  was  no
igniﬁcant  difference  between  groups  as  regards  height.
The  duration  of  surgery  in  group  I  ranged  from
0.0  to  110.0  min  with  a  mean  of  77.74  ±  12.30  min;  in
roup  II  ranged  from  63.0  to  113.0  min  with  a  mean  of
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76.29  ±  8.94  min;  in  group  III  ranged  from  65.0  to  110.0  min
with  a  mean  of  74.65  ±  8.85  min;  while  in  group  IV  ranged
from  70.0  to  100.0  min  with  a  mean  of  80.65  ±  9.64  min.
There  was  no  signiﬁcant  difference  between  groups  as
regards  duration.
The  total  fentanyl  dose  in  group  I  ranged  from  200.0  to
350.0  g with  a  mean  of  245.81  ±  39.73  g;  in  group  II  ranged
from  200.0  to  300.0  g  with  a  mean  of  245.81  ±  41.78  g;
in  group  III  ranged  from  200.0  to  300.0  g  with  a  mean  of
237.10  ±  34.08  g;  while  in  group  IV  ranged  from  200.0  to
350.0  g with  a  mean  of  251.61  ±  45.61  g.  There  was  no
signiﬁcant  difference  between  groups.
The  heart  rate  of  patients  in  group  I  ranged  from  70.0
to  80.0  beats  per  minute  with  a  mean  of  74.03  ±  4.17  beat
per  minute;  in  group  II  ranged  from  68.0  to  83.0  beats
per  minute  with  a  mean  of  74.90  ±  5.26  beats  per  minute;
in  group  III  ranged  from  70.0  to  78.0  beat  per  minute
with  a  mean  of  74.06  ±  3.24  beats  per  minute;  while  in
group  IV  ranged  from  70.0  to  80.0  beats  per  minute  with
a  mean  of  76.23  ±  3.29  beats  per  minute.  There  was  no
signiﬁcant  difference  between  groups  as  regards  heart
rate.
The  systolic  blood  pressure  in  group  I  ranged  from  100.0
to  120.0  mmHg  with  a  mean  of  110.97  ±  8.31  mmHg;  in
group  II  ranged  from  100.0  to  120.0  mmHg  with  a mean
of  115.16  ±  5.70  mmHg;  in  group  III  ranged  from  100.0  to
120.0  mmHg  with  a  mean  of  111.29  ±  7.18  mmHg;  while  in
group  IV  ranged  from  100.0  to  120.0  mmHg  with  a  mean
of  110.32  ±  8.36  mmHg.  There  was  no  signiﬁcant  difference
between  groups  as  regards  systolic  blood  pressure.
The  diastolic  blood  pressure  of  patients  in  group  I  ranged
from  70.0  to  80.0  mmHg  with  a  mean  of  73.87  ±  4.95  mmHg;
in  group  II  ranged  from  60.0  to  80.0  mmHg  with  a  mean
of  73.55  ±  6.61  mmHg;  in  group  III  ranged  from  70.0  to
90.0  mmHg  with  a  mean  of  75.81  ±  5.64  mmHg;  while  in
group  IV  ranged  from  70.0  to  84.0  mmHg  with  a  mean
of  76.94  ±  4.81  mmHg.  There  was  no  signiﬁcant  difference
between  groups  as  regards  diastolic  blood  pressure.
The  temperature  in  group  I  ranged  from  35.80  to  36.50
degrees  with  a  mean  of  36.15  ±  0.27  degrees;  in  group
II  ranged  from  35.80  to  36.50  degrees  with  a  mean  of
36.18  ±  0.27  degrees;  in  group  III  ranged  from  35.90  to  36.50
degrees  with  a  mean  of  36.18  ±  0.21  degrees;  while  in  group
IV  ranged  from  35.70  to  36.50  degrees  with  a  mean  of
36.24  ±  0.26  degrees.  There  was  no  signiﬁcant  difference
between  groups  as  regards  temperature.
The  SpO2 of  patients  in  group  I  ranged  from  98.0
to  100.0  mm  Hg  with  a  mean  of  99.03  ±  0.87  mmHg;  in
group  II  ranged  from  98.0  to  100.0  mmHg  with  a  mean
of  98.97  ±  0.71  mmHg;  in  group  III  ranged  from  98.0  to
100.0  mmHg  with  a  mean  of  99.19  ±  0.79  mmHg;  while  in
group  IV  ranged  from  98.0  to  100.0  mmHg  with  a  mean
of  98.90  ±  0.83  mmHg.  There  was  no  signiﬁcant  difference
between  groups  as  regards  SpO2.
The  sore  throat  incidence  in  group  I  patients  was  as  fol-
lows:  at  0  h  6.5%  +ve,  at  1  h  9.7%  +ve,  at  6  h  16.1%  +ve,  at
12  h  6.5%  +ve  and  at  24  h  3.2%  +ve.  All  cases  are  of  grade  1
severity.  The  sore  throat  incidence  in  group  II  patients  was
as  follows:  at  0  h  9.7%  +ve,  at  1  h  19.4%  +ve,  at  6  h  32.3%  +ve,
at  12  h  19.4%  +ve  and  at  24  h  16.1%  +ve.  Cases  are  grade  1
severity  except  at  6  and  12  h  where  all  cases  were  of  grade
2  severity.  The  sore  throat  incidence  in  group  III  patients
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as  as  follows:  at  0  h  19.4%  +ve,  at  1  h  32.3%  +ve,  at  6  h
5.2%  +ve,  at  12  h  38.7%  +ve  and  at  24  h  25.8%  +ve.  Cases
re  grade  1  severity  except  at  6  and  12  h  where  all  cases
ere  of  grade  2  severity.  The  sore  throat  incidence  in  group
V  patients  was  as  follows:  at  0  h  19.4%  +ve,  at  1  h  25.8%  +ve,
t  6  h  38.7%  +ve,  at  12  h  32.3%  +ve  and  at  24  h  19.4%  +ve.
ases  are  grade  1  severity  at  0  h  and  at  1,  6,  12  and  24  h
ere  of  grade  2  severity.
There  was  no  signiﬁcant  difference  between  groups  as
egards  sore  throat  incidence  at  0  h although  the  rela-
ion  between  groups  was  groups  I  <  II  <  III  =  IV.  There  was
igniﬁcant  difference  between  groups  I  and  III  at  1  h  but
on-signiﬁcant  difference  between  the  others  although  the
elation  between  groups  was  groups  II  <  III  >  IV.  There  was  sig-
iﬁcant  difference  between  groups  I,  III  and  IV  at  6,  12  h
here  there  were  less  cases  in  group  I  but  non-signiﬁcant  dif-
erence  between  the  others  although  the  relation  between
roups  was  groups  II  <  III  >  IV.  The  highest  incidence  of  POST
ccurred  at  6  h  after  extubation  in  all  groups.
There  was  no  signiﬁcant  difference  between  groups  at  0  h
here  all  the  cases  were  of  grade  1.  There  was  signiﬁcant
ifference  at  1  h  between  the  ﬁrst  three  groups  and  group
V  where  all  cases  in  this  group  were  of  grade  2  and  in  the
thers  were  of  grade  1.  There  was  signiﬁcant  difference  at
,  12  h  between  the  groups  where  all  cases  in  group  I  were
f  grade  1  and  in  the  others  were  of  grade  2.  There  was
igniﬁcant  difference  between  groups  at  24  h  where  all  cases
n  group  IV  were  of  grade  2  and  in  the  others  were  of  grade
.
The  Pethidine  dose  in  group  I ranged  from  40.0  to  60.0  mg
ith  a  mean  of  48.87  ±  6.02  mg;  in  group  II  ranged  from
0.0  to  60.0  mg  with  a  mean  of  48.23  ±  5.71  mg;  in  group  III
anged  from  35.0  to  60.0  mg  with  a  mean  of  47.26  ±  6.56  mg;
hile  in  group  IV  ranged  from  40.0  to  60.0  mg  with  a
ean  of  47.10  ±  4.79  mg.  There  was  no  signiﬁcant  differ-
nce  between  groups  as  regards  Pethidine  as  postoperative
nalgesia.
The  adverse  effects  in  group  I  patients  were  as  follows:
9.4%  nausea  and  vomiting;  9.7%  cough;  29.5%  hoarseness
nd  58.1%  dry  mouth.  Group  II:  30%  nausea  and  vomiting;
0%  cough;  50%  hoarseness  and  70%  dry  mouth.  Group  III:  32%
ausea  and  vomiting;  25%  cough;  55%  hoarseness  and  72%
ry  mouth.  Group  IV:  33%  nausea  and  vomiting;  26%  cough;
7%  hoarseness  and  73%  dry  mouth.  There  was  no  signiﬁcant
ifference  between  groups  as  regards  adverse  effects.
tatistical  analysis  of  the  data
ata  were  fed  to  the  computer  and  analyzed  using  IBM
PSS  software  package  version  20.0.8,9 Comparison  between
ifferent  groups  regarding  categorical  variables  was  tested
sing  Chi-square  test.  When  more  than  20%  of  the  cells  have
xpected  count  less  than  5,  correction  for  chi-square  was
onducted  using  Fisher’s  Exact  test  or  Monte  Carlo  correc-
ion.
The  distributions  of  quantitative  variables  were  tested
or  normality  using  Kolmogorov-Smirnov  test,  Shapiro--Wilk
est  and  D’Agstino  test,  also  Histogram  and  QQ  plot  were
sed  for  vision  test.  If  it  reveals  normal  data  distribution,
arametric  tests  were  applied.  If  the  data  were  abnormally
istributed,  non-parametric  tests  were  used.
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Figure  1  Comparison  between  the  different  studied  groups
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cccording  to  sore  throat  incidence  at  intervals  0,  1,  6,  12  and
4 h.
For  normally  distributed  data,  comparison  between  dif-
erent  groups  were  analyzed  using  F-test  (ANOVA)  and  Post
oc  test  (Scheffe)  for  pair  wise  comparison,  while  for  abnor-
ally  distributed  data,  Kruskal--Wallis  test  was  used  to
ompare  between  different  groups  and  Post  Hoc  test  was
ssessed  using  Mann--Whitney  Test.
Signiﬁcance  test  results  are  quoted  as  two-tailed  proba-
ilities.  Signiﬁcance  of  the  obtained  results  was  judged  at
he  5%  level.
iscussion
ccording  to  the  results  of  this  study,  the  highest  incidence
f  POST  occurred  at  the  sixth  hour  after  extubation,  but
ot  the  ﬁrst  hour.  Sore  throat  at  the  ﬁrst  few  hours  after
xtubation  might  be  masked  by  residual  analgesic  effects
fter  general  anesthesia  or  postoperative  pain  control.
There  was  no  signiﬁcant  difference  between  groups  as
egards  sore  throat  incidence  at  0  h.  There  was  signiﬁcant
ifference  between  group  I  and  III  at  1  h.  There  was  signiﬁ-
ant  difference  between  groups  I,  III  and  IV  at  6,  12  h.  The
ighest  incidence  of  POST  occurred  at  6  h  after  extubation
n  all  groups  (Fig.  1  and  Table  1).
There  were  more  cases  with  severe  degree  of  sore  throat
n  our  study  in  group  III  than  group  II  in  the  other  one  that
ight  be  attributed  to  our  smaller  sample  size.  Also,  there
ere  more  cases  with  severe  degree  of  sore  throat  in  group
II  in  our  study  than  group  II  in  the  other  one  which  might
e  related  to  our  smaller  sample  size  and  different  mode  of
pplication  of  lidocaine  with  mucosa  irritation  with  ethanol
nd  others.10,11
There  was  no  signiﬁcant  difference  between  groups  as
egards  severity  at  0  h  where  all  the  cases  were  of  grade  1.
here  was  signiﬁcant  difference  at  1,  6,  12,  24  h  between
roups  where  there  were  less  severity  with  benzydamine
nd  highest  severity  with  lidocaine  10%.  Other  workers  ﬁnd-
ngs  showed  signiﬁcant  difference  between  benzydamine
nd  other  3  groups  in  all  the  studied  hours.  There  was  sig-
iﬁcant  between  lidocaine  10%  and  lidocaine  5%.  Also,  there
as  signiﬁcant  difference  between  lidocaine  10%  and  saline.
here  was  more  cases  with  severe  grade  in  our  groups  III  and
10,11V  in  relation  to  the  other  study  where.
The  side  effects  of  topical  use  of  benzydamine  hydrochlo-
ide  include  local  numbness  or  burning,  stinging  sensation,
ausea  or  vomiting,  cough,  dry  mouth,  throat  discomfort,
n
c
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rowsiness,  and  headache,  which  may  be  evident  before
nduction  of  anesthesia.  To  avoid  these  adverse  effects,  we
pplied  benzydamine  hydrochloride  on  the  ETT  cuff  instead
f  perioperative  topical  application  to  the  oral  pharyngeal
avity.  We  found  that  this  maneuver  provided  excellent  pre-
ention  of  POST  and  reduced  its  incidence  from  saline  group
r  10%  lidocaine  spray  by  50%.12
Therefore,  the  application  of  benzydamine  hydrochlo-
ide  on  the  ETT  cuffs  may  provide  a  simple  and  effective
ethod  to  attenuate  the  incidence  and  severity  of  POST
fter  tracheal  intubation.  Application  of  lidocaine  spray
o  the  oral  pharyngeal  cavity  before  intubation  seems  to
ncrease  the  incidence  of  sore  throat.13,14 In  this  study,
e  also  found  that  spraying  10%  lidocaine  on  the  ETT  cuff
lso  increased  the  severity  of  POST  compared  with  5%  lido-
aine  gel  or  saline.  Ten  percent  lidocaine  solution  contains
thanol,  polyethylene  glycol  400,  menthol  and  saccharin
s  additives  in  the  solvent,  whereas  the  5%  lidocaine  solu-
ion  we  used  contained  sodium  chloride  as  an  additive.  In
act,  both  menthol  and  ethanol  can  irritate  tracheal  mucosa,
otentially  causing  tracheal  mucosa  damage,  thus  leading  to
ncreased  severity  of  POST.  However,  Soltani15 reported  that
sing  intra-cuff  lidocaine  (ETT  cuffs  preﬁlled  with  7--8  mL
f  2%  lidocaine  for  90  min  before  intubation  and  reﬁlled
ith  enough  2%  lidocaine  after  intubation)  was  superior  to
praying  topical  10%  lidocaine  on  laryngo-pharyngeal  struc-
ures  or  on  the  distal  end  of  the  ETT  for  decreasing  the
ncidence  of  POST.  Lidocaine  as  lubricating  agent  causing
ncrease  adverse  effects  on  anesthesia  wake  up.  Even  the
uff  rupture  sometimes.  Local  anesthetic  cuff  injected  is
 technique  for  less  pain  on  swallowing.  The  alkalinization
f  LA  by  adding  NAHCO3 increase  LA  diffusion  through  cuff
all.15
Theoretically,  chemical  irritation  from  the  additives  may
e  avoided  by  using  intra-cuff  lidocaine.  We  also  found  that
%  lidocaine  gel  did  not  attenuate  the  incidence  and  severity
f  POST  compared  with  normal  saline.  The  duration  of  the
nalgesic  effect  of  lidocaine  spray  applied  to  oral  mucosa
s  15  min.16 In  this  study,  at  the  end  of  surgery  (averaging
80  min  after  tracheal  intubation),  the  analgesic  effect  of
idocaine  spray  might  have  already  disappeared.  This  prob-
bly  explains  why  we  found  the  incidence  of  POST  to  be
o  different  between  the  5%  lidocaine  and  normal  saline
roups.
One  limitation  of  our  study  is  that  there  was  no  record  of
oughing  at  the  time  of  extubation.  Although  the  extubation
rotocol  was  the  same  in  all  groups,  we  did  not  evaluate  the
orrelation  between  the  frequency  of  coughing  at  the  time
f  extubation  and  the  incidence  of  POST.  The  second  limi-
ation  is  that  the  additives  to  5%  and  10%  lidocaine  solution
re  different,  which  may  have  inﬂuenced  the  result.
This  study  demonstrated  that  applying  benzydamine
ydrochloride  on  an  ETT  cuff  may  reduce  the  incidence  and
everity  of  POST  compared  with  applying  10%  lidocaine,  5%
idocaine,  and  normal  saline.  Application  of  10%  lidocaine
pray  should  be  avoided  because  of  worsening  of  POST  where
ncidence  and  severity  were  increased  in  relation  to  5%  lido-
aine  or  saline.  Applying  5%  lidocaine  on  the  ETT  cuff  does
ot  prevent  POST  but  better  than  saline.
One  limitation  of  our  study  is  that  there  was  no  record  of
oughing  or  bucking  at  the  time  of  extubation.  Although  the
xtubation  protocol  was  the  same  in  all  groups,  we  did  not
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Table  1  Comparison  between  the  different  studied  groups  according  to  sore  throat  incidence.
Sore  throat  incidence  Group  I  Group  II  Group  III  Group  IV  2 p
0  h
−ve  29  (93.5%)  28  (90.3%)  25  (80.6%)  25  (80.6%) 3.477 MCp  =  0.346
+ve 2  (6.5%)  3  (9.7%)  6  (19.4%)  6  (19.4%)
p1 FEp  =  1.000 FEp  =  0.255 FEp  =  0.255
p2 FEp  =  0.473 FEp  =  0.473
p3 p  =  1.000
1 h
−ve  28  (90.3%)  25  (80.6%)  21  (67.7%)  23  (74.2%) 5.066 p  =  0.149
+ve 3  (9.7%) 6  (19.4%)  10  (32.3%)  8  (25.8%)
p1 FEp  =  0.473 p  =  0.029a p  =  0.096
p2 p  =  0.246 p  =  0.544
p3 p  =  0.576
6 h
−ve  26  (83.9%)  21  (67.7%)  17  (54.8%)  19  (61.3%) 6.522 p  =  0.078
+ve 5  (16.1%)  10  (32.3%)  14  (45.2%)  12  (38.7%)
p1 p  =  0.138  p  =  0.013a p  =  0.046a
p2 p  =  0.297  p  =  0.596
p3 p  =  0.607
12 h
−ve  29  (93.5%)  25  (80.6%)  19  (61.3%)  21  (67.7%) 10.377a p  =  0.016a
+ve  2  (6.5%)  6  (19.4%)  12  (38.7)  10  (32.3%)
p1 FEp  =  0.255  p  =  0.002a p  =  0.010a
p2 p  =  0.093  p  =  0.246
p3 p  =  0.596
24 h
−ve  30  (96.8%)  26  (83.9%)  23  (74.2%)  25  (80.6%) 6.200 p  =  0.071
+ve 1  (3.2%)  5  (16.1%)  8  (25.8%)  6  (19.4%)
p1 FEp  =  0.195 FEp  =  0.026a  FEp  =  0.104
p2 p  =  0.349  p  =  0.740
p3 p  =  0.544
2, value of Chi square for comparing between the different studied groups; p1, p value for comparing between group I and each other
group; p2, p value for comparing between group II with groups III and IV; p3, p value for comparing between groups III and IV; MC, Monte
5
b
C
T
RCarlo test; FE, Fisher Exact test.
a Statistically signiﬁcant at p ≤ 0.05.
evaluate  the  correlation  between  the  frequency  of  coughing
or  bucking  at  the  time  of  extubation  and  the  incidence  of
POST.  The  second  limitation  is  that  benzydamine  hydrochlo-
ride  is  available  under  different  trade  names  in  different
countries,  its  formulations  are  quite  different  in  each  coun-
try,  and  the  additives  might  also  vary.  Moreover,  the  safety
and  dosage  of  benzydamine  hydrochloride  applied  to  the
trachea  need  further  investigation,  even  though  we  did  not
ﬁnd  any  adverse  effects  in  our  patients.  The  third  limitation
is  that  the  additives  to  5%  and  10%  lidocaine  solution  are
different,  which  may  have  inﬂuenced  the  result.
Conclusions
Benzydamine  hydrochloride  gel  on  the  ETT  cuff  is  a  simple
and  effective  method  to  reduce  the  incidence  and  severity
of  POST  in  relation  to  lidocaine  and  saline.  Application  of
10%  lidocaine  spray  should  be  avoided  because  of  worsening
of  POST  where  incidence  and  severity  is  increased.  Applying%  lidocaine  gel  on  the  ETT  cuff  does  not  prevent  POST  but
etter  than  lidocaine  10%  spray  or  saline.
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